Article
A clinically relevant heterozygous ATR mutation sensitizes colorectal cancer cells to replication stress.
Scientific reports - 31 Mar 2022
Egger Tom, Bordignon Benoît, Coquelle Arnaud
Abstract excerpt
Colorectal cancer (CRC) ranks third among the most frequent malignancies and represents the second most common cause of cancer-related deaths worldwide. By interfering with the DNA replication process of cancer cells, several chemotherapeutic molecules used in CRC therapy induce replication stress (RS). At the cellular level, this stress is managed by the ATR-CHK1 pathway, which activates the replication...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
